Follow The Short Interest: Is Buying Simulations Plus Incorporated (NASDAQ:SLP) Here Good Idea?

November 16, 2016 - By Peter Erickson   ·   0 Comments

Follow The Short Interest: Is Buying Simulations Plus Incorporated (NASDAQ:SLP) Here Good Idea?

The stock of Simulations Plus Incorporated (NASDAQ:SLP) registered an increase of 1.73% in short interest. SLP’s total short interest was 329,900 shares in November as published by FINRA. Its up 1.73% from 324,300 shares, reported previously. With 28,200 shares average volume, it will take short sellers 12 days to cover their SLP’s short positions. The short interest to Simulations Plus Incorporated’s float is 3.1%. The stock closed at $9 during the last session. It is down 3.09% since April 14, 2016 and is uptrending. It has underperformed by 1.59% the S&P500.

Simulations Plus, Inc. develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The company has a market cap of $150.13 million. The Firm offers five software products for pharmaceutical research. It has a 31.34 P/E ratio. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.

Insitutional Activity: The institutional sentiment decreased to 0.72 in Q2 2016. Its down 0.97, from 1.69 in 2016Q1. The ratio turned negative, as 12 funds sold all Simulations Plus, Inc. shares owned while 13 reduced positions. 3 funds bought stakes while 15 increased positions. They now own 4.10 million shares or 10.61% less from 4.59 million shares in 2016Q1.
Skylands Ltd Company holds 0.31% of its portfolio in Simulations Plus, Inc. (NASDAQ:SLP) for 248,834 shares. Geode Cap Management Limited Company, a Massachusetts-based fund reported 58,765 shares. Susquehanna Int Grp Incorporated Ltd Liability Partnership has 12,315 shares for 0% of their US portfolio. Tower Research Capital Ltd Liability Com (Trc) holds 0.01% or 7,840 shares in its portfolio. Vanguard Inc holds 0% of its portfolio in Simulations Plus, Inc. (NASDAQ:SLP) for 531,554 shares. Ancora Ltd Llc last reported 0.17% of its portfolio in the stock. Royal Retail Bank Of Canada, a Ontario – Canada-based fund reported 4,000 shares. Blackrock Invest Mgmt Ltd accumulated 1,852 shares or 0% of the stock. Moreover, Granite Prtn Ltd Co has 0.18% invested in Simulations Plus, Inc. (NASDAQ:SLP) for 306,988 shares. Punch Assocs Management holds 444,184 shares or 0.39% of its portfolio. Stanley accumulated 0.06% or 20,416 shares. Moreover, California Public Employees Retirement Sys has 0% invested in Simulations Plus, Inc. (NASDAQ:SLP) for 39,200 shares. Fincl Bank Of America De last reported 0% of its portfolio in the stock. Morgan Stanley accumulated 0% or 73,011 shares. Dimensional Fund Advisors Lp has 0% invested in the company for 339,427 shares.

SLP Company Profile

Simulations Plus, Inc., incorporated on July 17, 1996, is a well-known provider of simulation and modeling software for pharmaceutical discovery and development. The Firm offers its services and products through two business units, including Simulations Plus, Inc. and Cognigen Corporation. The Firm also provides consulting services ranging from early drug discovery through preclinical and clinical trial data analysis and reporting to regulatory agencies. The Firm offers over seven software products for pharmaceutical research and development, including three simulation programs that provide time-dependent results on solving various sets of differential equations: GastroPlus, DDDPlus and MembranePlus; three programs that are based on predicting and analyzing static properties of chemicals: ADMET Predictor, MedChem Designer and MedChem Studio, which is a combination of ADMET Predictor, MedChem Designer and MedChem Studio is called its ADMET Design Suite, and a program that supports data analysis and reporting through its secure cloud called KIWI. The Company’s PKPlus software product is used for non-compartmental pharmacokinetic analysis and reporting. The Firm distributes its products and offers its services in North America, South America, Europe, Japan, Australia, New Zealand, India, Singapore and the People’s Republic of China.

More recent Simulations Plus, Inc. (NASDAQ:SLP) news were published by: Quotes.Wsj.com which released: “News Simulations Plus Inc.SLP” on February 11, 2011. Also Businesswire.com published the news titled: “Simulations Plus Reports FY2016 and Fourth Quarter FY2016 Financial Results” on November 11, 2016. Seekingalpha.com‘s news article titled: “Shorting Simulations Plus Is Silly” with publication date: February 23, 2016 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Peter Erickson


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>